Heather Chambless Herrington, MD - Medicare Otolaryngology in Burlington, VT

Heather Chambless Herrington, MD is a medicare enrolled "Otolaryngology" physician in Burlington, Vermont. She went to Oregon Health Sciences University School Of Medicine and graduated in 2006 and has 18 years of diverse experience with area of expertise as Otolaryngology. She is a member of the group practice University Of Vermont Medical Center Inc and her current practice location is 111 Colchester Ave, Burlington, Vermont. You can reach out to her office (for appointments etc.) via phone at (802) 847-2700.

Heather Chambless Herrington is licensed to practice in Vermont (license number 042.0012412) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1679607170.

Contact Information

Heather Chambless Herrington, MD
111 Colchester Ave,
Burlington, VT 05401-1473
(802) 847-2700
Not Available



Physician's Profile

Full NameHeather Chambless Herrington
GenderFemale
SpecialityOtolaryngology
Experience18 Years
Location111 Colchester Ave, Burlington, Vermont
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Heather Chambless Herrington attended and graduated from Oregon Health Sciences University School Of Medicine in 2006
  NPI Data:
  • NPI Number: 1679607170
  • Provider Enumeration Date: 03/15/2007
  • Last Update Date: 07/24/2012
  Medicare PECOS Information:
  • PECOS PAC ID: 1658527460
  • Enrollment ID: I20120810000218

Medical Identifiers

Medical identifiers for Heather Chambless Herrington such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1679607170NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Y00000XOtolaryngology 042.0012412 (Vermont)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Univ. Of Vermont - Fletcher Allen Health CareBurlington, VTHospital
Porter Hospital, IncMiddlebury, VTHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
University Of Vermont Medical Center Inc3779491071994

News Archive

ACLJ: Abortion funding issue cannot be resolved without a specific exemption

The American Center for Law and Justice (ACLJ), focusing on constitutional law, said today despite President Obama's insistence that "no federal dollars will be used to fund abortions" – the fact is that such a proclamation does not guarantee that abortion won't become a mandatory health care "benefit" under health care reform.

Lung inflammation from influenza and other infections could be turned off following new discovery

A new discovery could lead to treatments which turn off the inflammation in the lungs caused by influenza and other infections, according to a study published in the journal Nature Immunology.

New global map shows difficult-to-treat malaria strain remains prevalent in Asia, Latin America

"Declining malaria deaths in Africa and progress toward an effective malaria vaccine are raising hopes the disease will soon be eradicated worldwide," but "researchers at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in Philadelphia, Pennsylvania, [on Monday] unveiled a new global malaria map that raises new concerns about the disease," VOA News writes.

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board (DSMB) for the global Phase 2/3 study of opaganib in patients with severe COVID-19, unanimously recommended to continue the study following a pre-scheduled futility review of unblinded efficacy data from the first 135 patients treated in the study and safety data from the first 175 patients.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Heather Chambless Herrington allows following entities to bill medicare on her behalf.
Entity NameUniversity Of Vermont Medical Center Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1659309615
PECOS PAC ID: 3779491071
Enrollment ID: O20040406001047

News Archive

ACLJ: Abortion funding issue cannot be resolved without a specific exemption

The American Center for Law and Justice (ACLJ), focusing on constitutional law, said today despite President Obama's insistence that "no federal dollars will be used to fund abortions" – the fact is that such a proclamation does not guarantee that abortion won't become a mandatory health care "benefit" under health care reform.

Lung inflammation from influenza and other infections could be turned off following new discovery

A new discovery could lead to treatments which turn off the inflammation in the lungs caused by influenza and other infections, according to a study published in the journal Nature Immunology.

New global map shows difficult-to-treat malaria strain remains prevalent in Asia, Latin America

"Declining malaria deaths in Africa and progress toward an effective malaria vaccine are raising hopes the disease will soon be eradicated worldwide," but "researchers at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in Philadelphia, Pennsylvania, [on Monday] unveiled a new global malaria map that raises new concerns about the disease," VOA News writes.

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board (DSMB) for the global Phase 2/3 study of opaganib in patients with severe COVID-19, unanimously recommended to continue the study following a pre-scheduled futility review of unblinded efficacy data from the first 135 patients treated in the study and safety data from the first 175 patients.

Read more Medical News

› Verified 4 days ago

Entity NamePorter Hospital Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1134457013
PECOS PAC ID: 1850365180
Enrollment ID: O20050919000862

News Archive

ACLJ: Abortion funding issue cannot be resolved without a specific exemption

The American Center for Law and Justice (ACLJ), focusing on constitutional law, said today despite President Obama's insistence that "no federal dollars will be used to fund abortions" – the fact is that such a proclamation does not guarantee that abortion won't become a mandatory health care "benefit" under health care reform.

Lung inflammation from influenza and other infections could be turned off following new discovery

A new discovery could lead to treatments which turn off the inflammation in the lungs caused by influenza and other infections, according to a study published in the journal Nature Immunology.

New global map shows difficult-to-treat malaria strain remains prevalent in Asia, Latin America

"Declining malaria deaths in Africa and progress toward an effective malaria vaccine are raising hopes the disease will soon be eradicated worldwide," but "researchers at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in Philadelphia, Pennsylvania, [on Monday] unveiled a new global malaria map that raises new concerns about the disease," VOA News writes.

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board (DSMB) for the global Phase 2/3 study of opaganib in patients with severe COVID-19, unanimously recommended to continue the study following a pre-scheduled futility review of unblinded efficacy data from the first 135 patients treated in the study and safety data from the first 175 patients.

Read more Medical News

› Verified 4 days ago

Entity NameCentral Vermont Medical Center Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1023028784
PECOS PAC ID: 9335138817
Enrollment ID: O20051220000393

News Archive

ACLJ: Abortion funding issue cannot be resolved without a specific exemption

The American Center for Law and Justice (ACLJ), focusing on constitutional law, said today despite President Obama's insistence that "no federal dollars will be used to fund abortions" – the fact is that such a proclamation does not guarantee that abortion won't become a mandatory health care "benefit" under health care reform.

Lung inflammation from influenza and other infections could be turned off following new discovery

A new discovery could lead to treatments which turn off the inflammation in the lungs caused by influenza and other infections, according to a study published in the journal Nature Immunology.

New global map shows difficult-to-treat malaria strain remains prevalent in Asia, Latin America

"Declining malaria deaths in Africa and progress toward an effective malaria vaccine are raising hopes the disease will soon be eradicated worldwide," but "researchers at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in Philadelphia, Pennsylvania, [on Monday] unveiled a new global malaria map that raises new concerns about the disease," VOA News writes.

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board (DSMB) for the global Phase 2/3 study of opaganib in patients with severe COVID-19, unanimously recommended to continue the study following a pre-scheduled futility review of unblinded efficacy data from the first 135 patients treated in the study and safety data from the first 175 patients.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Heather Chambless Herrington is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Heather Chambless Herrington, MD
19 Kingsland Ter,
Burlington, VT 05401-5501

Ph: () -
Heather Chambless Herrington, MD
111 Colchester Ave,
Burlington, VT 05401-1473

Ph: (802) 847-2700

News Archive

ACLJ: Abortion funding issue cannot be resolved without a specific exemption

The American Center for Law and Justice (ACLJ), focusing on constitutional law, said today despite President Obama's insistence that "no federal dollars will be used to fund abortions" – the fact is that such a proclamation does not guarantee that abortion won't become a mandatory health care "benefit" under health care reform.

Lung inflammation from influenza and other infections could be turned off following new discovery

A new discovery could lead to treatments which turn off the inflammation in the lungs caused by influenza and other infections, according to a study published in the journal Nature Immunology.

New global map shows difficult-to-treat malaria strain remains prevalent in Asia, Latin America

"Declining malaria deaths in Africa and progress toward an effective malaria vaccine are raising hopes the disease will soon be eradicated worldwide," but "researchers at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in Philadelphia, Pennsylvania, [on Monday] unveiled a new global malaria map that raises new concerns about the disease," VOA News writes.

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board (DSMB) for the global Phase 2/3 study of opaganib in patients with severe COVID-19, unanimously recommended to continue the study following a pre-scheduled futility review of unblinded efficacy data from the first 135 patients treated in the study and safety data from the first 175 patients.

Read more News

› Verified 4 days ago


Otolaryngology Doctors in Burlington, VT

Tamara Rimash, M.D.
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 111 Colchester Ave, Burlington, VT 05401
Phone: 802-847-0000    
Dr. George Kurien, MD FRCSC
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 111 Colchester Ave, Burlington, VT 05401
Phone: 802-847-4537    Fax: 802-847-8198
Erin Tracy Ostby, M.D.
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 111 Colchester Ave Fl 4, Burlington, VT 05401
Phone: 802-847-4535    Fax: 802-847-8198
Dr. William John Brundage, MD
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 111 Colchester Ave, West Pavilion-level 4, Burlington, VT 05401
Phone: 802-847-4535    Fax: 802-847-8198
Dr. Donna Jean Millay, MD
Otolaryngology
Medicare: Medicare Enrolled
Practice Location: 111 Colchester Ave, West Pavilion-level 4 Otolaryngology, Burlington, VT 05401
Phone: 802-847-4537    Fax: 802-847-8198
Dr. Gary Patrick Landrigan, MD
Otolaryngology
Medicare: Medicare Enrolled
Practice Location: 111 Colchester Ave, West Pavilion-level 4, Burlington, VT 05401
Phone: 802-847-9393    Fax: 802-847-8198

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.